2101
Immunotherapy: Mechanism, Outcomes and Markers
Saturday, March 1, 2014: 8:15 AM-9:45 AM
Convention Center, Ground Level, Exhibit Hall A
1.50 CME/ 1.80 CE
Moderator:
Linda Cox , MD FAAAAI
Learning Objectives:
  1. Discuss the benefits of specific immunotherapy
  2. Describe factors affecting safety of specific allergy immunotherapy
  3. Discuss the use of biomarkers to predict the response to immunotherapy to pollens
8:15 AM
Tolerance to Allergens: How it Develops and How it Can be Induced
Cezmi A. Akdis, MD FAAAAI
Handouts
  • Akdis2101Handout.pdf (492.8 kB)
  • 8:45 AM
    Biomarker Predictors of Effective Immunotherapy
    Stephen R. Durham, MA MD FRCP
    9:15 AM
    SIT Outcomes: Examining the Data for Efficacy, Safety, Adherence and Costs
    Linda Cox, MD FAAAAI
    See more of: Plenary